Vor(VOR) - 2025 Q4 - Annual Results

Financial Position - As of December 31, 2025, Vor Biopharma Inc. reported cash, cash equivalents, and short-term investments of approximately $450 million[6] - The financial information provided is preliminary and has not been audited, indicating potential changes upon completion of the audited financial statements[7] Upcoming Events - Vor Biopharma Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, from 10:30 am to 11:10 am PT[9]